We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Restasis Antitrust Suits Paused For MDL Panel Review

Law360, New York (January 8, 2018, 3:03 PM EST) -- A Texas federal court on Friday stayed a series of lawsuits accusing Allergan PLC of violating antitrust laws to keep generics for the dry-eye medication Restasis off the market, until the Judicial Panel on Multidistrict Litigation decides whether the cases should be combined.

U.S. District Judge Rodney Gilstrap granted Allergan’s Dec. 20 stay request, pending the JPML’s Jan. 25 hearing. He asked for an update by Feb. 17, at which point he’ll reconsider the stay.

The proposed class actions are all from Restasis buyers who claim...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

FWK Holdings, LLC v. Allergan, Inc.


Case Number

2:17-cv-00747

Court

Texas Eastern

Nature of Suit

Anti-Trust

Judge

Rodney Gilstrap

Date Filed

November 17, 2017


Case Title

IN RE: Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation


Case Number

2819

Court

Judicial Panel on Multidistrict Litigation

Nature of Suit

Judge

Nina Gershon

Date Filed

November 17, 2017


Case Title

Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund v. Allergan, Inc.


Case Number

2:17-cv-00755

Court

Texas Eastern

Nature of Suit

Anti-Trust

Judge

Rodney Gilstrap

Date Filed

November 27, 2017


Case Title

Rochester Drug Co-Operative, Inc. v. Allergan, Inc.


Case Number

2:17-cv-00766

Court

Texas Eastern

Nature of Suit

Anti-Trust

Judge

Rodney Gilstrap

Date Filed

December 11, 2017


Case Title

Allied Services Division Welfare Fund v. Allergan, Inc.


Case Number

2:17-cv-00775

Court

Texas Eastern

Nature of Suit

Anti-Trust

Judge

Rodney Gilstrap

Date Filed

December 15, 2017

Law Firms

Companies

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.